Comprehensive Guide to Imfinzi (Durvalumab): Pricing, Uses, and More Imfinzi (durvalumab) is an innovative immunotherapy drug that has transformed the treatment landscape for various types of cancer. Developed by AstraZeneca, it belongs to the class of anti-PD-1 and PD-L1 monoclonal antibodies, functioning as an immune checkpoint inhibitor. This guide aims to provide an in-depth look […]
sourcing from China
©2023. sourcifychina.com All Rights Reserved.